AstraZeneca Pharmaceuticals (Ireland) DAC (AstraZeneca)

Lobbying Organisation AstraZeneca Pharmaceuticals (Ireland) DAC

Date published 21 Jan, 2026

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2025 to 31 Dec, 2025

Specific Details Alexion - Rare disease policy and access to medicines

Intended results Brief TDs and Senators in progress with Programme of Government commitments on rare diseases and access to medicines

Name of person primarily responsible for lobbying on this activity Andrew Brown

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (2-5)

Meetings in Leinster House on Programme of Government commitments on rare diseases and access to medicines

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Pádraig O'Sullivan TD (Dáil Éireann, the Oireachtas)

John Lahart TD (Dáil Éireann, the Oireachtas)

Naoise O'Cearúil TD (Dáil Éireann, the Oireachtas)

Shane Moynihan TD (Dáil Éireann, the Oireachtas)

Maria Byrne Senator (Seanad)

Frank Feighan TD (Dáil Éireann, the Oireachtas)

Kiera Keogh TD (Dáil Éireann, the Oireachtas)